  monsanto mtc unit see oper loss       new york, april  - monsanto corp g.d. 
searl co unit report oper loss , mainli due expens research development. 
    searl chairman sheldon gilgor searl oper loss  less  mln oper loss . 
    searl first quarter sale up . 
 mln dlr  mln dlr year ago quarter. 
 searl sale  mln dlrs. 
    gilgor compani intend sale three billion dlr mid-s. 
    compani anticip approv japan, u.s., italy, spain u.k. 
ulcer treatment drug cytotech. 
    paper publish drug shown prevent flare-up ulcer longer period time tagamet, made smithklin beckman corp skb. 
    drug searl pipelin includ tissu plasminogen activ (tpa), made differ process genentech gene tpa, expect approv market year.
